Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 246

1.

Levetiracetam versus carbamazepine in patients with late poststroke seizures: a multicenter prospective randomized open-label study (EpIC Project).

Consoli D, Bosco D, Postorino P, Galati F, Plastino M, Perticoni GF, Ottonello GA, Passarella B, Ricci S, Neri G, Toni D; EPIC Study.

Cerebrovasc Dis. 2012;34(4):282-9. doi: 10.1159/000342669. Epub 2012 Nov 1.

PMID:
23128439
2.

KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy.

Trinka E, Marson AG, Van Paesschen W, Kälviäinen R, Marovac J, Duncan B, Buyle S, Hallström Y, Hon P, Muscas GC, Newton M, Meencke HJ, Smith PE, Pohlmann-Eden B; KOMET Study Group.

J Neurol Neurosurg Psychiatry. 2013 Oct;84(10):1138-47. doi: 10.1136/jnnp-2011-300376. Epub 2012 Aug 29.

PMID:
22933814
3.

Cognitive outcome of antiepileptic treatment with levetiracetam versus carbamazepine monotherapy: a non-interventional surveillance trial.

Helmstaedter C, Witt JA.

Epilepsy Behav. 2010 May;18(1-2):74-80. doi: 10.1016/j.yebeh.2010.02.011. Epub 2010 May 13.

PMID:
20462801
4.

Levetiracetam monotherapy for late poststroke seizures in the elderly.

Kutlu G, Gomceli YB, Unal Y, Inan LE.

Epilepsy Behav. 2008 Oct;13(3):542-4. doi: 10.1016/j.yebeh.2008.04.025. Epub 2008 Jun 6.

PMID:
18539085
5.

[The use of levetiracetam in monotherapy in post-stroke seizures in the elderly population].

García-Escrivá A, López-Hernández N.

Rev Neurol. 2007 Nov 1-15;45(9):523-5. Spanish.

6.
7.

The LaLiMo Trial: lamotrigine compared with levetiracetam in the initial 26 weeks of monotherapy for focal and generalised epilepsy--an open-label, prospective, randomised controlled multicenter study.

Rosenow F, Schade-Brittinger C, Burchardi N, Bauer S, Klein KM, Weber Y, Lerche H, Evers S, Kovac S, Hallmeyer-Elgner S, Winkler G, Springub J, Niedhammer M, Roth E, Eisensehr I, Berrouschot J, Arnold S, Schröder M, Beige A, Oertel WH, Strzelczyk A, Haag A, Reif PS, Hamer HM; LaLiMo Study Group.

J Neurol Neurosurg Psychiatry. 2012 Nov;83(11):1093-8. doi: 10.1136/jnnp-2011-301999. Epub 2012 May 17.

PMID:
22595362
8.

Comparative effectiveness of levetiracetam, valproate and carbamazepine among elderly patients with newly diagnosed epilepsy: subgroup analysis of the randomized, unblinded KOMET study.

Pohlmann-Eden B, Marson AG, Noack-Rink M, Ramirez F, Tofighy A, Werhahn KJ, Wild I, Trinka E.

BMC Neurol. 2016 Aug 23;16(1):149. doi: 10.1186/s12883-016-0663-7.

10.

Measurement of levetiracetam drug levels to assist with seizure control and monitoring of drug interactions with other anti-epileptic medications (AEMs).

Stepanova D, Beran RG.

Seizure. 2014 May;23(5):371-6. doi: 10.1016/j.seizure.2014.02.003. Epub 2014 Feb 17.

11.

Monotherapy of lamotrigine versus carbamazepine in patients with poststroke seizure.

Gilad R, Sadeh M, Rapoport A, Dabby R, Boaz M, Lampl Y.

Clin Neuropharmacol. 2007 Jul-Aug;30(4):189-95.

PMID:
17762314
12.
13.

Tolerability, safety, and side effects of levetiracetam versus phenytoin in intravenous and total prophylactic regimen among craniotomy patients: a prospective randomized study.

Fuller KL, Wang YY, Cook MJ, Murphy MA, D'Souza WJ.

Epilepsia. 2013 Jan;54(1):45-57. doi: 10.1111/j.1528-1167.2012.03563.x. Epub 2012 Jun 27.

14.

Use of levetiracetam in hospitalized patients.

Falip M, Carreño M, Amaro S, Donaire A, Delgado R, Toledo M, Maestro I.

Epilepsia. 2006 Dec;47(12):2186-8.

15.

Adjunctive levetiracetam in children, adolescents, and adults with primary generalized seizures: open-label, noncomparative, multicenter, long-term follow-up study.

Delanty N, Jones J, Tonner F.

Epilepsia. 2012 Jan;53(1):111-9. doi: 10.1111/j.1528-1167.2011.03300.x. Epub 2011 Nov 2.

16.

Neuropsychological and neurophysiologic effects of carbamazepine and levetiracetam.

Meador KJ, Gevins A, Loring DW, McEvoy LK, Ray PG, Smith ME, Motamedi GK, Evans BM, Baum C.

Neurology. 2007 Nov 27;69(22):2076-84.

PMID:
18040014
17.

The effects of levetiracetam, carbamazepine, and sodium valproate on P100 and P300 in epileptic patients.

Tumay Y, Altun Y, Ekmekci K, Ozkul Y.

Clin Neuropharmacol. 2013 Mar-Apr;36(2):55-8. doi: 10.1097/WNF.0b013e318285f3da.

PMID:
23503548
18.

Efficacy and tolerability of anti-epileptic drugs-an internet study.

Wieshmann UC, Baker G.

Acta Neurol Scand. 2017 May;135(5):533-539. doi: 10.1111/ane.12698. Epub 2016 Oct 18.

PMID:
27757951
19.

Levetiracetam: safety and efficacy in neonatal seizures.

Ramantani G, Ikonomidou C, Walter B, Rating D, Dinger J.

Eur J Paediatr Neurol. 2011 Jan;15(1):1-7. doi: 10.1016/j.ejpn.2010.10.003. Epub 2010 Nov 19.

PMID:
21094062
20.

Efficacy of anti-epileptic drugs in patients with gliomas and seizures.

van Breemen MS, Rijsman RM, Taphoorn MJ, Walchenbach R, Zwinkels H, Vecht CJ.

J Neurol. 2009 Sep;256(9):1519-26. doi: 10.1007/s00415-009-5156-9. Epub 2009 May 12.

PMID:
19434440

Supplemental Content

Support Center